Wix's 70% Plunge: Is the Base44 Boom Already Priced In?

The market has spoken, and the verdict is severe. Wix stock is down 70.1% over the past year, trading around $68 as of last week. That's a brutal decline, especially when compared to the S&P 500's roughly 15% gain in the same period. The core question now is whether this is a fundamental reset or a classic overreaction. The catalyst for the latest leg down appears to be a strategic exit by a concentrated investor.

On February 17, Metavasi Capital reported selling its entire stake in Wix, a move that declined the quarter-end value of the position by $6.57 million. The fund, which previously held a 2.0% stake, is also downsizing its portfolio. While a single fund's sale doesn't dictate a stock's fate, it often signals a reassessment of risk versus reward. For Wix, that risk profile has been under pressure for months.

The decline follows a 51.6% drop in 2025, driven by a familiar tension. On one side, the platform is growing steadily, with third-quarter revenue up 14% year-over-year. On the other, investors are nervous about rising costs and the disruptive potential of AI tools that could automate website building. This is the expectation gap in action: the market is pricing in existential threat and margin pressure, even as the core subscription business delivers solid, recurring numbers.

The guidance reset is a key part of this story. Management has raised its annual revenue outlook, in part due to the rapid growth of its new AI product, Base 44. Yet the stock's plunge suggests the market is skeptical that this new growth can offset the perceived headwinds. The recent sale by Metavasi Capital adds a layer of institutional confirmation to that skepticism. The setup now is clear: the stock is deeply discounted, but the market's priced-in reality is one of a company at a crossroads, where the promise of AI may not yet outweigh the fears of disruption.

Earnings Reality vs. Market Expectations: The Q3 Beat and Guidance Raise

The third-quarter print delivered a classic "beat and raise" story, but the market's reaction has been muted. Wix posted EPS of $1.68, crushing the $1.05 estimate by 60%. Revenue also grew, coming in at $505.19 million, up from a year ago. On the surface, this is a strong quarter. Yet the stock's subsequent decline suggests the beat was already priced in, or that the raise came with a costly trade-off.

The real pivot was in the guidance. Management raised its full-year 2025 revenue outlook to a range of $1.99-$2.00 billion, now expecting 13%-14% year-over-year growth. This upward revision is directly tied to the rapid adoption of its AI product, Base 44. In theory, this should be bullish news. But the mechanism behind the raise reveals a shift in priorities that the market may not have fully discounted.

For the quarter, Wix shifted from net income to a small net loss. The guidance raise, therefore, signals a deliberate focus on longer-term recurring revenue at the expense of near-term profitability. This is a common playbook for growth companies: sacrifice margins now to lock in future cash flows. The market's skepticism, evidenced by the stock's plunge, likely stems from concerns that the promised growth from Base 44 is not yet sufficient to offset the near-term hit to earnings, or that the cost of driving that growth will be higher than expected.

The expectation gap here is clear. The beat on EPS was a positive surprise, but the guidance raise came with a caveat about profitability. For investors, the question is whether the market is correctly pricing in the near-term pain for future gain, or if it's undervaluing the disruptive potential of Base 44. The stock's reaction suggests the latter is the current consensus.

The Base44 Wild Card: Priced-In Growth or Future Catalyst?

Base44 is the central bet in Wix's future, and its explosive growth trajectory is the only thing supporting the company's raised revenue guidance. The numbers are staggering. In under six months, the AI app builder has scaled from just $3 million to over $50 million in Annual Recurring Revenue (ARR). Analyst models suggest it could reach $50 million to $100 million in ARR within a year of its acquisition. This isn't just a new product; it's a massive expansion into the 'vibe-coding' AI software market, where a single business might need dozens of custom internal apps, vastly increasing the total addressable market beyond simple website building.

The expectation gap here is massive. The market has priced in a deep skepticism about Wix's ability to navigate the AI disruption. Yet Base44's performance-traffic share jumping from almost nothing in June to over 10% by October-suggests it is capturing demand faster than anyone anticipated. This growth is the core reason management raised its full-year revenue outlook. The question is whether this potential is already reflected in the stock's depressed valuation.

A recent analyst model provides a stark answer. By assuming conservative growth and margins, the model projects a $156 share price by December 2027, implying a 22% annualized return over the next two years. That math hinges entirely on Base44 hitting its potential. If the product continues scaling at its current pace, the upside is significant. But if adoption stalls or the promised margins fail to materialize, the risk is that the stock remains under pressure.

The bottom line is that Base44 is the only real catalyst left to drive the stock higher. The market's 70% plunge suggests it is not yet pricing in this AI-driven growth story. For investors, the setup is a classic expectation arbitrage: the company is trading at a discount to its potential, but that potential is entirely contingent on a single, high-stakes product execution.

Catalysts and Risks: What to Watch for the Next Expectation Shift

The next major event is the Q4 earnings call scheduled for March 4, 2026. This will be the first major test of the raised full-year guidance and the true health of the Base44 growth engine. Investors will scrutinize two things: the actual progress of Base44 against the company's ambitious targets, and the clarity on the path to profitability. The market's deep skepticism means even a solid execution could be met with a "sell the news" reaction if it fails to exceed the newly set bar.

A key risk is that the raised revenue guidance itself is a form of "sandbagging". By setting a higher bar for 2025, management may be creating a lower hurdle for future quarters, making subsequent beats easier to achieve. This move could be seen as a tactical reset to manage expectations, but it also raises questions about the durability of the growth story. If Base44's momentum slows, the company could be left with a guidance range that is too high relative to its actual capabilities, leading to another round of disappointment.

On the capital allocation front, Wix has a powerful tool to support the stock: a $2 billion stock buyback authorization. This plan acts as a floor for capital allocation, signaling management's confidence in the business's future cash flows. However, its effectiveness is entirely contingent on the company generating sustained free cash flow. The recent shift to a net loss for the quarter highlights the tension between growth investment and profitability. For the buyback to be meaningful, Wix must demonstrate it can scale Base44 while also improving its bottom-line efficiency.

The bottom line is that the stock's depressed valuation leaves little room for error. The March 4 call is the next catalyst that will either validate the AI-driven growth story or confirm the market's fears. The outcome will hinge on whether Base44's ARR continues its explosive climb and whether the company can show a credible path to turning that growth into profitable cash. Any stumble on either front could widen the expectation gap, while a clear acceleration could spark a long-overdue re-rating.